What Has Been the Growth Trajectory for the Nanomedicine Market in Recent Years?
The nanomedicine market has seen considerable growth due to a variety of factors.
• The size of the nanomedicine market has seen a swift expansion in the past few years. The market, which is expected to be worth $331.61 billion in 2024, is projected to reach a value of $379.24 billion in 2025, indicating a compound annual growth rate (CAGR) of 14.4%.
This surge during the historical period is a result of enhanced comprehension of molecular biology, a rise in chronic illnesses, an increased call for targeted drug distribution systems, the development of nanoparticle imaging technologies and a growing elderly population.
How Does the Forecast Look for the Nanomedicine Market?
The nanomedicine market is expected to maintain its strong growth trajectory in upcoming years.
• In the forthcoming years, a swift expansion is anticipated in the nanomedicine market size, which is projected to increase to $690.96 billion by 2029 with a compound annual growth rate (CAGR) of 16.2%.
This expected surge during the forecast duration is due to sustained advancements in nanotechnology studies, escalating investments in nanomedicine research and development, a growing concentration on personalized medicine, broadening applications of nanomedicine in cancer treatments, and amalgamation of nanomedicine in therapies for infectious diseases. The forecast period will see critical trends such as the creation of multi-purpose nanoparticles for therapeutic applications and imaging, focus on nanoparticle-based diagnosis and imaging agents, application of nanomedicine in regenerative medicine, an increase in utilization of nanomedicine in targeted therapy for neurological disorders, and collaboration and alliances in nanomedicine investigation and commercialization.
What Main Forces Are Fueling Expansion In The Nanomedicine Market?
The escalating global incidence of complex and chronic diseases is predicted to aid the expansion of the nanomedicine market during the forecasted timeline. The use of nanomedicine in the treatment of enduring diseases such as cardiovascular issues, diabetes, cancer, dementia, among others is on the rise, due to its efficiency in speeding up drug metabolism in the human body. For example, as per Alzheimer's Disease International, which is part of the International Federation of Alzheimer's Associations, it is estimated that dementia currently affects over 50 million individuals worldwide. This number is expected to double every 20 years, reaching approximately 80 million by 2030, and 152 million by 2050. Concurrently, global cancer incidents are projected to escalate to 28.4 million new cases by 2040. Such escalating rates of chronic diseases are projected to spark an increased demand for efficient therapeutic treatments, such as nanomedicine, thus propelling the expansion of the nanomedicine market.
What Are The Primary Segments In The Global Nanomedicine Market?
The nanomedicine market covered in this report is segmented –
1) By Type: Nanoparticles, Nanoshells, Nanotubes, Nanodevices, Other Types
2) By Modality: Diagnostics, Treatments
3) By Application: Clinical Oncology, Infectious Diseases, Clinical Cardiology, Orthopedics, Other Applications
Subsegments:
1) By Nanoparticles: Lipid-Based Nanoparticles, Polymeric Nanoparticles, Metallic Nanoparticles, Ceramic Nanoparticles
2) By Nanoshells: Gold Nanoshells, Silver Nanoshells, Silica Nanoshells
3) By Nanotubes: Carbon Nanotubes (CNTs), Polymer Nanotubes
4) By Nanodevices: Nanosensors, Nanorobots, Nanoscale Imaging Devices
5) By Other Types: Dendrimers, Quantum Dots, Nanocarriers
Pre-Book The Nanomedicine Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
Which Key Trends Are Driving Changes In The Nanomedicine Market?
Leading firms in the nanomedicine market, including Waters Corporation, are shifting their focus towards the creation and innovation of unique products such as the dynapro zetastar. The objective is to increase their market revenue significantly. This exceptional instrument is designed to perform simultaneous calculations of dynamic and static light scattering, as well as dynamic and electrophoretic light scattering (DLS/SLS/ELS). Waters Corporation, renowned in the US for their expertise in manufacturing analytical laboratory instruments and equipment, launched dynapro zetastar in September 2023 to enable more accurate nanoparticle analysis. The zetastar instrument enhances the precision of complex biologic development by integrating various light scattering techniques, performing adaptive data capture, and auto-assessing data reliability. Furthermore, it drastically improves sensitivity and speed of measurements, even when using extremely small sample volumes. The unique flow cell structure of the zetastar instrument enables it to connect with an autosampler, thus significantly augmenting laboratory efficiency and productivity by allowing a series of unattended calculations that could span multiple hours or even overnight.
Who Are the Key Players in the Nanomedicine Market?
Major companies operating in the nanomedicine market include:
• Pfizer Inc.
• Ablynx NV
• Amgen Inc.
• Arrowhead Research Inc.
• Bio-Gate AG
• Celgene Corporation
• F. Hoffmann-La Roche AG
• GE Healthcare
• Gilead Sciences Inc.
• Merck AG
• Nanospectra Biosciences
• Nanotherapeutics Inc.
• NanoViricides Inc
• Novartis AG
• Sanofi S. A.
• Abraxis Bioscience Inc.
• Alnylam Pharmaceuticals Inc.
• Arrowhead Pharmaceuticals Inc.
• AuraSense Therapeutics LLC
• BIND Therapeutics Inc.
• Camurus AB
• Cerulean Pharma Inc.
• CytImmune Sciences
• Fujifilm Holdings
• Nanobiosym Inc.
• Nanobiotix SA
• Nanogen Inc.
• Nanoparticle BioChem Inc.
• Nanospective Inc.
• Nanosphere Health Sciences Inc.
• Nanosys Inc.
• PerkinElmer Inc.
• Selecta Biosciences Inc.
What Is The Most Dominant Region In The Nanomedicine Market?
North America was the largest region in the nanomedicine market in 2024.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nanomedicine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
